These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1085 related items for PubMed ID: 29279588

  • 1. Comparison of the sensitivity and specificity of p16/Ki-67 dual staining and HPV DNA testing of abnormal cervical cytology in the detection of histology proven cervical intraepithelial neoplasia grade 2 and above (CIN 2+).
    Tay TKY, Lim KL, Hilmy MH, Thike AA, Goh ST, Song LH, Hwang JSG, Mantoo S.
    Malays J Pathol; 2017 Dec; 39(3):257-265. PubMed ID: 29279588
    [Abstract] [Full Text] [Related]

  • 2. Good performance of p16/Ki-67 dual-stain cytology for detection and post-treatment surveillance of high-grade CIN/VAIN in a prospective, cross-sectional study.
    Liu W, Gong J, Xu H, Zhang D, Xia N, Li H, Song K, Lv T, Chen Y, Diao Y, Jao J, Dai S, Zhao P, Yao Q.
    Diagn Cytopathol; 2020 Jul; 48(7):635-644. PubMed ID: 32275355
    [Abstract] [Full Text] [Related]

  • 3. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
    Ovestad IT, Dalen I, Hansen E, Loge JL, Dybdahl BM, Dirdal MB, Moltu P, Berland JM.
    Cancer Cytopathol; 2017 Apr; 125(4):283-291. PubMed ID: 27918650
    [Abstract] [Full Text] [Related]

  • 4. [Clinical value of p16INK4a immunocytochemistry in cervical cancer screening].
    Song FB, Du H, Xiao AM, Wang C, Huang X, Yan PS, Liu ZH, Qu XF, Belinson JEROMEL, Wu RF.
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov 25; 55(11):784-790. PubMed ID: 33228350
    [Abstract] [Full Text] [Related]

  • 5. p16/Ki-67 dual staining has a better accuracy than human papillomavirus (HPV) testing in women with abnormal cytology under 30 years old.
    Pirtea L, Secosan C, Margan M, Moleriu L, Balint O, Grigoras D, Sas I, Horhat F, Jianu A, Ilina R.
    Bosn J Basic Med Sci; 2019 Nov 08; 19(4):336-341. PubMed ID: 29924960
    [Abstract] [Full Text] [Related]

  • 6. Improved abnormal Pap smear triage using cervical cancer biomarkers.
    Killeen JL, Dye T, Grace C, Hiraoka M.
    J Low Genit Tract Dis; 2014 Jan 08; 18(1):1-7. PubMed ID: 23760145
    [Abstract] [Full Text] [Related]

  • 7. P16/Ki-67 Dual Staining in Positive Human Papillomavirus DNA Testing for Predictive Diagnosis of Abnormal Cervical Lesions in Northeastern Thai Women.
    Aromseree S, Wongjumpa W, Ekalaksananan T, Temtanakitpaisan A, Kleebkaow P, Srisathaporn S, Tongchai P, Pientong C.
    Asian Pac J Cancer Prev; 2022 Oct 01; 23(10):3405-3411. PubMed ID: 36308365
    [Abstract] [Full Text] [Related]

  • 8. Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results.
    Bergeron C, Ikenberg H, Sideri M, Denton K, Bogers J, Schmidt D, Alameda F, Keller T, Rehm S, Ridder R, PALMS Study Group.
    Cancer Cytopathol; 2015 Jun 01; 123(6):373-81. PubMed ID: 25891096
    [Abstract] [Full Text] [Related]

  • 9. Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study.
    Ikenberg H, Bergeron C, Schmidt D, Griesser H, Alameda F, Angeloni C, Bogers J, Dachez R, Denton K, Hariri J, Keller T, von Knebel Doeberitz M, Neumann HH, Puig-Tintore LM, Sideri M, Rehm S, Ridder R, PALMS Study Group.
    J Natl Cancer Inst; 2013 Oct 16; 105(20):1550-7. PubMed ID: 24096620
    [Abstract] [Full Text] [Related]

  • 10. Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial.
    Wright TC, Behrens CM, Ranger-Moore J, Rehm S, Sharma A, Stoler MH, Ridder R.
    Gynecol Oncol; 2017 Jan 16; 144(1):51-56. PubMed ID: 28094038
    [Abstract] [Full Text] [Related]

  • 11. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
    El-Zein M, Gotlieb W, Gilbert L, Hemmings R, Behr MA, Franco EL, STAIN-IT Study Group.
    Int J Cancer; 2021 Jan 15; 148(2):492-501. PubMed ID: 32781481
    [Abstract] [Full Text] [Related]

  • 12. Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study.
    Uijterwaal MH, Witte BI, Van Kemenade FJ, Rijkaart D, Ridder R, Berkhof J, Balfoort-van der Meij GA, Bleeker MC, Snijders PJ, Meijer CJ.
    Br J Cancer; 2014 Mar 18; 110(6):1579-86. PubMed ID: 24518601
    [Abstract] [Full Text] [Related]

  • 13. Triage of LSIL/ASC-US with p16/Ki-67 dual staining and human papillomavirus testing: a 2-year prospective study.
    White C, Bakhiet S, Bates M, Keegan H, Pilkington L, Ruttle C, Sharp L, O' Toole S, Fitzpatrick M, Flannelly G, O' Leary JJ, Martin CM.
    Cytopathology; 2016 Aug 18; 27(4):269-76. PubMed ID: 26932360
    [Abstract] [Full Text] [Related]

  • 14. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
    Wu Y, Zhao J, Hu J, Wu XW, Zhu LR.
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov 25; 52(11):734-739. PubMed ID: 29179267
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of p16(INK4a)/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion.
    Waldstrøm M, Christensen RK, Ørnskov D.
    Cancer Cytopathol; 2013 Mar 25; 121(3):136-45. PubMed ID: 22987560
    [Abstract] [Full Text] [Related]

  • 17. Dual immunostaining of cervical cytology specimens with atypical squamous cells for p16/Ki-67 does not exclude the existence of a high-grade squamous intraepithelial lesion.
    Koo YJ, Hahn HS, Lee IH, Lim KT, Lee KH, Kim HS, Kim TJ, Chun YK, Kim HS, Hong SR.
    Virchows Arch; 2013 Nov 25; 463(5):689-96. PubMed ID: 24081504
    [Abstract] [Full Text] [Related]

  • 18. Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data.
    Uijterwaal MH, Polman NJ, Witte BI, van Kemenade FJ, Rijkaart D, Berkhof J, Balfoort-van der Meij GA, Ridder R, Snijders PJ, Meijer CJ.
    Int J Cancer; 2015 May 15; 136(10):2361-8. PubMed ID: 25345358
    [Abstract] [Full Text] [Related]

  • 19. p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study.
    Schmidt D, Bergeron C, Denton KJ, Ridder R, European CINtec Cytology Study Group.
    Cancer Cytopathol; 2011 Jun 25; 119(3):158-66. PubMed ID: 21442767
    [Abstract] [Full Text] [Related]

  • 20. Performance of HPV Genotyping Combined with p16/Ki-67 in Detection of Cervical Precancer and Cancer Among HPV-Positive Chinese Women.
    Jiang MY, Wu Z, Li T, Yu L, Zhang SK, Zhang X, Qu P, Sun P, Xi MR, Liu X, Liao G, Sun L, Zhang Y, Chen W, Qiao YL.
    Cancer Prev Res (Phila); 2020 Feb 25; 13(2):163-172. PubMed ID: 31871224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.